May 11, 2012
1 min read
Save

Behind the Lab Door

News from retina research laboratories across the country.

Click here to see this month’s studies.

Randomized, Multi-center, Phase 2 Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination with Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema with Involvement of the FoveAL Center (the iDEAL Study)
Wilmer Eye Institute at Johns Hopkins

Intravitreal Ketorolac for Chronic Uveitis: A Phase 1 Investigational Safety Study (INCITE)
Vanderbilt Eye Institute